Literature DB >> 35276262

Aortic visceral segment instability is evident following thoracic endovascular aortic repair for acute and subacute type B aortic dissection.

Juliet Blakeslee-Carter1, Hellen A Potter2, Charles A Banks1, Marc Passman1, Benjamin Pearce1, Graeme McFarland1, Sukgu M Han2, Salvatore Scali3, Gregory A Magee2, Emily Spangler1, Adam W Beck4.   

Abstract

BACKGROUND: Anatomic remodeling within the thoracic aorta following thoracic endovascular aortic repair (TEVAR) for type B aortic dissection (TBAD) has been well documented. However, less is known about the response of the untreated visceral aorta. In the present study, we investigated the visceral aortic behavior after TEVAR for acute or subacute TBAD to identify any associations with the clinical outcomes.
METHODS: A multicenter retrospective review was performed of all imaging studies for all patients who had undergone TEVAR for acute (0-14 days) and subacute (14-90 days) nontraumatic TBAD from 2006 to 2020. The cohort was inclusive of those with uncomplicated, high-risk, and complicated (defined in accordance with the Society for Vascular Surgery reporting guidelines) dissections. Centerline aortic measurements of the true and false lumen and total aortic diameter (TAD) were taken at standardized locations relative to the aortic anatomy within each aortic zone (the zones were defined by the Society for Vascular Surgery reporting guidelines). Diameter changes over time were evaluated using repeated measures mixed effects linear growth modeling. Visceral segment instability (VSI) was defined as any growth in the TAD of ≥5 mm within aortic zones 5 through 9.
RESULTS: A total of 82 patients were identified. The median length of imaging follow-up was 2.1 years (interquartile range, 0.75-4.5 years), with 15% of the cohort having follow-up >5 years. VSI was present in 55% of the cohort, with an average maximal increase in the TAD of 10.4 ± 6.3 mm during a median follow-up of 2.1 years (interquartile range, 0.75-4.5 years). Approximately one third of the cohort had experienced rapid VSI (growth ≥5 mm in the first year), and 4.8% of the cohort had developed a large paravisceral aortic aneurysm (TAD ≥5 cm) secondary to VSI. Linear growth modeling identified significant predictable growth in the TAD across all visceral zones. Zone 7 had the highest rate of TAD dilation, with a fixed effect estimated rate of 1.3 mm/y (95% confidence interval [CI], 0.23-2.1; P = .022). The preoperative factor most strongly associated with VSI was a cumulative number of zones dissected of six or more (odds ratio, 6.4; 95% CI, 1.07-8.6; P = .041). The odds for aortic reintervention were significantly increased for cases in which VSI led to the development of a paravisceral aortic aneurysm of ≥5 cm (odds ratio, 3.7; 95% CI, 1.1-13; P = .038).
CONCLUSIONS: VSI was identified in most patients who had undergone TEVAR for management of acute and subacute TBAD. The preoperative anatomic features such as the dissection extent, rather than the procedural details of graft coverage, might play a more significant role in VSI occurrence. Significant TAD growth had occurred in all visceral segments. These results highlight the importance of lifelong surveillance following TEVAR and identified a subset of patients who might have an increased risk of reintervention.
Copyright © 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Remodeling; TEVAR; Type B aortic dissection

Mesh:

Year:  2022        PMID: 35276262      PMCID: PMC9329185          DOI: 10.1016/j.jvs.2022.02.046

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.860


  32 in total

1.  Prospective multicenter clinical trial (STABLE) on the endovascular treatment of complicated type B aortic dissection using a composite device design.

Authors:  Joseph V Lombardi; Richard P Cambria; Christoph A Nienaber; Roberto Chiesa; Omke Teebken; Anthony Lee; Peter Mossop; Priya Bharadwaj
Journal:  J Vasc Surg       Date:  2011-12-09       Impact factor: 4.268

2.  Risk factors associated with aortic remodeling in patients with Stanford type B aortic dissection after thoracic endovascular aortic repair.

Authors:  X L Wang; H Y Huang; Z Li; Y S Yu; Y Q Hu; W X Ye; F Hua; Y H Chen; H Ni; Q W Ding; Z Y Shen
Journal:  Genet Mol Res       Date:  2015-10-02

3.  Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection.

Authors:  Thomas T Tsai; Rossella Fattori; Santi Trimarchi; Eric Isselbacher; Truls Myrmel; Arturo Evangelista; Stuart Hutchison; Udo Sechtem; Jeanna V Cooper; Dean E Smith; Linda Pape; James Froehlich; Arun Raghupathy; James L Januzzi; Kim A Eagle; Christoph A Nienaber
Journal:  Circulation       Date:  2006-11-13       Impact factor: 29.690

Review 4.  Outcome of endovascular treatment of acute type B aortic dissection.

Authors:  Jun D Parker; Jonathan Golledge
Journal:  Ann Thorac Surg       Date:  2008-11       Impact factor: 4.330

5.  Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial.

Authors:  Christoph A Nienaber; Stephan Kische; Hervé Rousseau; Holger Eggebrecht; Tim C Rehders; Guenther Kundt; Aenne Glass; Dierk Scheinert; Martin Czerny; Tilo Kleinfeldt; Burkhart Zipfel; Louis Labrousse; Rossella Fattori; Hüseyin Ince
Journal:  Circ Cardiovasc Interv       Date:  2013-08-06       Impact factor: 6.546

6.  Five-year results from the Study of Thoracic Aortic Type B Dissection Using Endoluminal Repair (STABLE I) study of endovascular treatment of complicated type B aortic dissection using a composite device design.

Authors:  Joseph V Lombardi; Richard P Cambria; Christoph A Nienaber; Roberto Chiesa; Peter Mossop; Stéphan Haulon; Qing Zhou
Journal:  J Vasc Surg       Date:  2019-05-28       Impact factor: 4.268

7.  False lumen embolization in chronic aortic dissection promotes thoracic aortic remodeling at midterm follow-up.

Authors:  Quentin Pellenc; Arnaud Roussel; Romain De Blic; Antoine Girault; Pierre Cerceau; Iannis Ben Abdallah; Olivier Milleron; Guillaume Jondeau; Yves Castier
Journal:  J Vasc Surg       Date:  2019-03-06       Impact factor: 4.268

8.  Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) reporting standards for type B aortic dissections.

Authors:  Joseph V Lombardi; G Chad Hughes; Jehangir J Appoo; Joseph E Bavaria; Adam W Beck; Richard P Cambria; Kristofer Charlton-Ouw; Mohammad H Eslami; Karen M Kim; Bradley G Leshnower; Thomas Maldonado; T Brett Reece; Grace J Wang
Journal:  J Vasc Surg       Date:  2020-01-27       Impact factor: 4.268

9.  Predictors of outcome after endovascular repair for chronic type B dissection.

Authors:  K Mani; R E Clough; O T A Lyons; R E Bell; T W Carrell; H A Zayed; M Waltham; P R Taylor
Journal:  Eur J Vasc Endovasc Surg       Date:  2012-02-09       Impact factor: 7.069

10.  Serial CT volume and thrombus length measurements after endovascular repair of Stanford type B aortic dissection.

Authors:  Benedikt V Czermak; Ammar Mallouhi; Reinhold Perkmann; Iris E Steingruber; Peter Waldenberger; Beate Neuhauser; Gustav Fraedrich; Tarzis Jung; Werner R Jaschke
Journal:  J Endovasc Ther       Date:  2004-02       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.